Cargando…

Neuroprotection by (Endo)Cannabinoids in Glaucoma and Retinal Neurodegenerative Diseases

BACKGROUND: Emerging neuroprotective strategies are being explored to preserve the retina from degeneration, that occurs in eye pathologies like glaucoma, diabetic retinopathy, age-related macular degeneration, and retinitis pigmentosa. Incidentally, neuroprotection of retina is a defending mechanis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rapino, Cinzia, Tortolani, Daniel, Scipioni, Lucia, Maccarrone, Mauro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6120105/ https://www.ncbi.nlm.nih.gov/pubmed/28738764 http://dx.doi.org/10.2174/1570159X15666170724104305

Ejemplares similares

(Endo)Cannabinoids and Gynaecological Cancers
por: Taylor, Anthony H., et al.
Publicado: (2020)

Modulation of Type-1 and Type-2 Cannabinoid Receptors by Saffron in a Rat Model of Retinal Neurodegeneration
por: Maccarone, Rita, et al.
Publicado: (2016)

Rare Phytocannabinoids Exert Anti-Inflammatory Effects on Human Keratinocytes via the Endocannabinoid System and MAPK Signaling Pathway
por: Tortolani, Daniel, et al.
Publicado: (2023)

Autophagic and endo-lysosomal dysfunction in neurodegenerative disease
por: Malik, Bilal R., et al.
Publicado: (2019)

Endo-cannabinoids system and the toxicity of cannabinoids with a biotechnological approach
por: Niaz, Kamal, et al.
Publicado: (2017)

Aβ Chronic Exposure Promotes an Activation State of Microglia through Endocannabinoid Signalling Imbalance
por: Scipioni, Lucia, et al.
Publicado: (2023)

Altered Expression of Type-1 and Type-2 Cannabinoid Receptors in Celiac Disease
por: Battista, Natalia, et al.
Publicado: (2013)

Emerging Role of (Endo)Cannabinoids in Migraine
por: Leimuranta, Pinja, et al.
Publicado: (2018)

Modulation of Endocannabinoid-Binding Receptors in Human Neuroblastoma Cells by Tunicamycin
por: Rapino, Cinzia, et al.
Publicado: (2019)

Neuroprotective therapy for retinal neurodegenerative diseases by stem cell secretome
por: Usategui-Martín, Ricardo, et al.
Publicado: (2020)

Exo- and Endo-cannabinoids in Depressive and Suicidal Behaviors
por: Mannekote Thippaiah, Srinagesh, et al.
Publicado: (2021)

Effects of Rare Phytocannabinoids on the Endocannabinoid System of Human Keratinocytes
por: Di Meo, Camilla, et al.
Publicado: (2022)

Intracellular Molecular Targets and Signaling Pathways Involved in Antioxidative and Neuroprotective Effects of Cannabinoids in Neurodegenerative Conditions
por: Tadijan, Ana, et al.
Publicado: (2022)

Characterization of Endocannabinoid System and Interleukin Profiles in Ovine AEC: Cannabinoid Receptors Type-1 and Type-2 as Key Effectors of Pro-Inflammatory Response
por: Greco, Luana, et al.
Publicado: (2020)

Cannabinoids and Cancer
por: Falasca, Marco, et al.
Publicado: (2021)

The impact of phyto- and endo-cannabinoids on central nervous system diseases：A review
por: Zhang, Shan-Shan, et al.
Publicado: (2022)

Progranulin and GPNMB: interactions in endo-lysosome function and inflammation in neurodegenerative disease
por: Gillett, Drew A., et al.
Publicado: (2023)

Disease modification and Neuroprotection in neurodegenerative disorders
por: Cummings, Jeffrey
Publicado: (2017)

The Role of Reticulons in Neurodegenerative Diseases
por: Chiurchiù, Valerio, et al.
Publicado: (2013)

Neuroprotection in Glaucoma
por: Doozandeh, Azadeh, et al.
Publicado: (2016)

Neuroprotection in glaucoma
por: Vishwaraj, C R, et al.
Publicado: (2022)

Therapeutic Potential of Cannabinoids in Glaucoma
por: Lindner, Theresa, et al.
Publicado: (2023)

The TRPV1 Receptor Is Up-Regulated by Sphingosine 1-Phosphate and Is Implicated in the Anandamide-Dependent Regulation of Mitochondrial Activity in C2C12 Myoblasts
por: Standoli, Sara, et al.
Publicado: (2022)

VEGF-A Is Necessary and Sufficient for Retinal Neuroprotection in Models of Experimental Glaucoma
por: Foxton, Richard H., et al.
Publicado: (2013)

Neuroprotection by Wld(S) depends on retinal ganglion cell type and age in glaucoma
por: Risner, Michael L., et al.
Publicado: (2021)

Seventh European Workshop on Cannabinoid Research and IACM Eighth Conference on Cannabinoids in Medicine
por: Cheer, Joseph F., et al.
Publicado: (2016)

Neuroprotection in glaucoma
por: Vasudevan, Sushil K, et al.
Publicado: (2011)

Neuroprotection in Glaucoma
por: Nilforushan, Naveed
Publicado: (2012)

SYK coordinates neuroprotective microglial responses in neurodegenerative disease
por: Ennerfelt, Hannah, et al.
Publicado: (2022)

Metabolic Vulnerability in the Neurodegenerative Disease Glaucoma
por: Inman, Denise M., et al.
Publicado: (2017)

Neuroprotective effects of berry fruits on neurodegenerative diseases
por: Subash, Selvaraju, et al.
Publicado: (2014)

Intravitreal stem cell paracrine properties as a potential neuroprotective therapy for retinal photoreceptor neurodegenerative diseases
por: Puertas-Neyra, Kevin, et al.
Publicado: (2020)

Neuroprotective Effects of Citicoline in in Vitro Models of Retinal Neurodegeneration
por: Matteucci, Andrea, et al.
Publicado: (2014)

The anti-inflammatory agent bindarit acts as a modulator of fatty acid-binding protein 4 in human monocytic cells
por: Oddi, Sergio, et al.
Publicado: (2019)

Neuroprotection of retinal ganglion cells in vivo using the activation of the endogenous cannabinoid signaling system in mammalian eyes
por: Maguire, Greg, et al.
Publicado: (2022)

Tribute to Professor Raphael Mechoulam, The Founder of Cannabinoid and Endocannabinoid Research
por: Maccarrone, Mauro
Publicado: (2022)

Anti-Inflammatory Effects of Fatty Acid Amide Hydrolase Inhibition in Monocytes/Macrophages from Alzheimer’s Disease Patients
por: Chiurchiù, Valerio, et al.
Publicado: (2021)

Risk Factors for Retinal Ganglion Cell Distress in Glaucoma and Neuroprotective Potential Intervention
por: Vernazza, Stefania, et al.
Publicado: (2021)

Alzheimer's Disease and Glaucoma: Imaging the Biomarkers of Neurodegenerative Disease
por: Valenti, Denise A.
Publicado: (2011)

Endogenous and Synthetic Cannabinoids as Therapeutics in Retinal Disease
por: Kokona, Despina, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_5gphifro2r4vvv4tfbtop6kji1